Founded in 1982, Britannia Pharmaceuticals Limited is a UK-based global speciality pharmaceutical company, therapeutically focussing on neurology and CNS.

With over 30 years’ experience in movement disorders, we possess deep and wide knowledge within the disease area and have developed a strong and successful track record in launching and marketing products across Europe, East Asia (including Japan), Australasia, MENA and the US.

Britannia’s in-house capabilities cover all of the major functions you would normally expect to see within a pharmaceutical company, including R&D, Business Development, Product Development, Clinical, Regulatory and Quality Services, Market Access, Supply Chain and Global Marketing.